FGFR-TKI resistance in cancer: current status and perspectives

por Yue, Sitong, Li, Yukun, Chen, Xiaojuan, Wang, Juan, Li, Meixiang, Chen, Yongheng, Wu, Daichao
Publicado 2021

Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors

por Qu, Lingzhi, Chen, Xiaojuan, Wei, Hudie, Guo, Ming, Dai, Shuyan, Jiang, Longying, Li, Jun, Yue, Sitong, Chen, Zhuchu, Chen, Yongheng
Publicado 2022

Author Correction: Structure-based design of a dual-warhead covalent inhibitor of FGFR4

por Chen, Xiaojuan, Li, Huiliang, Lin, Qianmeng, Dai, Shuyan, Yue, Sitong, Qu, Lingzhi, Li, Maoyu, Guo, Ming, Wei, Hudie, Li, Jun, Jiang, Longying, Xu, Guangyu, Chen, Yongheng
Publicado 2022

Structure-based design of a dual-warhead covalent inhibitor of FGFR4

por Chen, Xiaojuan, Li, Huiliang, Lin, Qianmeng, Dai, Shuyan, Yue, Sitong, Qu, Lingzhi, Li, Maoyu, Guo, Ming, Wei, Hudie, Li, Jun, Jiang, Longying, Xu, Guangyu, Chen, Yongheng
Publicado 2022